Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Endocrinology|March 5, 2021
A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A PhosphorylationFederica Mangili, Donatella Treppiedi, Rosa Catalano, et al.Frontiers in Endocrinology|August 22, 2022
Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5 homo- and hetero-dimer formationDonatella Treppiedi, Giusy Marra, Genesio Di Muro, et al.Frontiers in Endocrinology|June 17, 2022
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 InfectionDonatella Treppiedi, Giusy Marra, Genesio Di Muro, et al.Endocrine-Related Cancer|June 4, 2021
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophsDonatella Treppiedi, Genesio Di Muro, Giusy Marra, et al.Frontiers in Endocrinology|June 20, 2022
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary CellsFederica Mangili, Emanuela Esposito, Donatella Treppiedi, et al.Cancers|June 28, 2023
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor CellsGenesio Di Muro, Federica Mangili, Emanuela Esposito, et al.Cancers|August 27, 2021
Genetic Profiling of a Cohort of Italian Patients with ACTH-Secreting Pituitary Tumors and Characterization of a Novel USP8 Gene VariantDonatella Treppiedi, Anna Maria Barbieri, Genesio Di Muro, et al.International Journal of Molecular Sciences|April 13, 2024
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) CellsGenesio Di Muro, Rosa Catalano, Donatella Treppiedi, et al.International Journal of Cancer|November 11, 2024
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomasEmanuela Esposito, Giusy Marra, Rosa Catalano, et al.Pharmacological Research|October 17, 2025
Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinomaEmma Nozza, Emanuela Esposito, Genesio Di Muro, et al.Pageof 2